Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: A novel biomarker of proteolytic injury

Journal of Neurosurgery

Volumn 107, Issue 4, 2007, Pages 792-796

  Lewis, Stephen B ^a   Velat, Gregory J ^a   Miralia, Lynn ^a   Papa, Linda ^b   Aikman, Jada M ^c   Wolper, Regina A ^a   Firment, Chris S ^a,b   Ming, Chen Liu ^b   Pineda, Jose A ^d   Wang, Kevin K W ^b   Hayes, Ronald L ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

II spectrin; Biomarker; Cell death; Subarachnoid hemorrhage

Indexed keywords

FODRIN;

ADULT; AGED; ANASTOMOSIS; ARTICLE; BRAIN INJURY; BRAIN VASOSPASM; CEREBROSPINAL FLUID DRAINAGE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING;

ADULT; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; BIOLOGICAL MARKERS; CALPAIN; CASPASES; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NECROSIS; SPECTRIN; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; VASOSPASM, INTRACRANIAL;

EID: 35148821734     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/JNS-07/10/0792     Document Type: Article

References (23)

1. Aikman J, O'Steen B, Silver X, Torres R, Boslaugh S, Blackband S, et al: Alpha-II-spectrin after controlled cortical impact in the immature rat brain. Dev Neurosci 28:457-465, 2006
2. Bavbek M, Polin R, Kwan AL, Arthur AS, Kassell NF, Lee KS, et al: Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 29:1930-1936, 1998
3. Brilstra EH, Hop JW, Rinkel GJE: Quality of life after perimesencephalic haemorrhage. J Neurol Neurosurg Psychiatry 63:382-384, 1997
4. Brouwers PJ, Dippel DW, Vermeulen M, Lindsay KW, Hasan D, van Gijn J: Amount of blood on computed tomography as an independent predictor after aneurysm rupture. Stroke 24:809-814, 1993
5. D'Avella D, Aguennouz M, Angileri FF, de Divitiis O, Germano A, Toscano A, et al: Detection of α-II spectrin and breakdown products in humans after severe traumatic brain injury. Acad Emerg Med 11:515, 2004
6. Frijns CJM, Fijnheer R, Algra A, van Mourik JA, van Gijn J, Rinkel GJE: Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome. J Neurol Neurosurg Psychiatry 77:77-83, 2006
7. Germano A, Costa C, DeFord SM, Angileri FF, Arcadi F, Pike BR, et al: Systemic administration of a calpain inhibitor reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J Neurotrauma 19:887-896, 2002
8. Hop JW, Rinkel GJE, Algra A, van Gijn J: Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. Stroke 29:798-804, 1998
9. Ingebrigtsen T, Romner B: Biochemical serum markers of traumatic brain injury. J Trauma 52:798-808, 2002
10. Linn FHH, Rinkel GJE, Algra A, van Gijn J: Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 27:625-629, 1996
11. Petzold A, Keir G, Kerr M, Kay A, Kitchen N, Smith M, et al: Early identification of secondary brain damage in subarachnoid hemorrhage: a role for glial fibrillary acidic protein. J Neurotrauma 23:1179-1184, 2006
12. Petzold A, Keir G, Lim D, Smith M, Thompson EJ: Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res Bull 61:281-285, 2003
13. Pike BR, Flint J, Dave JR, Lu XCM, Wang KKW, Tortella FC, et al: Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived αII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 24:98-106, 2004
14. Pike BR, Flint J, Dutta S, Johnson E, Wang KKW, Hayes RL: Accumulation of non-erythroid αII-spectrin and calpain-cleaved αII-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J Neurochem 78:1297-1306, 2001
15. Pike BR, Zhao X, Newcomb JK, Posmantur RM, Wang KKW, Hayes RL: Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport 9:2437-2442, 1998
16. Polin RS, Bavbek M, Shaffrey ME, Billups K, Bogaev CA, Kassell NF, et al: Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 89:559-567, 1998
17. Posmantur R, Kampfl A, Siman R, Liu J, Zhao X, Clifton GL, et al: A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 77:875-888, 1997
18. Saatman KE, Murai H, Bartus RT, Smith DH, Haywayd NJ, Perri BR, et al: Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc Natl Acad Sci U S A 93:3428-3433, 1996
19. Solenski NJ, Haley ECJ, Kassell NF, Kongable G, Germanson T, Truskowski L, et al: Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 23:1007-1017, 1995
20. Sudlow CLM, Warlow CP: Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 28:491-499, 1997
21. van Gijn J, Rinkel GJE: Subarachnoid haemorrhage: diagnosis, causes and management. Brain 124:249-278, 2001
22. van Gijn J, Van Dongen KJ, Vermeulen M, Hijdra A: Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology 35:493-497, 1985
23. Zhao X, Newcomb JK, Pike BR, Wang KKW, d'Avella D, Hayes RL: Novel characteristics of glutamate-induced cell death in primary septohippocampal cultures: relationship to calpain and caspase-3 protease activation. J Cereb Blood Flow Metab 20:550-562, 2000